<DOC>
	<DOC>NCT01689194</DOC>
	<brief_summary>This clinical trial is Phase II trial for evaluating efficacy of induction chemotherapy using Genexol-PM + cisplatin for locally advanced head and neck cancer. The investigators try to evaluate response rate of Genexol-PM + cisplatin chemotherapy, and safety profile.</brief_summary>
	<brief_title>Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>locally advanced head and neck squamous cell carcinoma oral cavity, oropharynx, hypopharynx, larynx measurable lesion unresectable age 18 or more ECOG 0 or 1 distant metastasis pregnancy prior chemotherapy or radiation therapy 2ndary malignancy other unfit medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>